17 July 2009
This week, the Biotechnology Industry Organization (BIO) and the Generic Pharmaceutical Association (GPhA) issued their opposing statements in reaction to the July 13 passage of an amendment from the US Senate Committee on Health, Education, Labor, and Pensions (HELP) regarding the creation of a pathway for the approval of new competitors of biologic drugs.
 |
17 July 2009
The UK's Medicines and Healthcare Regulatory Agency (MHRA) intends to keep a close eye on the safety of the swine flu antiviral medicines Tamiflu and Relenza as their use increases, by using an online reporting system.
|
16 July 2009
Through its subsidiary IMA Life Srl, IMA SpA has acquired 51% of PharmaSiena Srl, which designs and produces filling machines for ampoules and syringes in aseptic environments.
|
10 July 2009
Spain's first in-border facility to develop pandemic and seasonal influenza vaccines will be built under a 60 million euro programme sponsored and led by the Spanish Ministry of Health.
|
10 July 2009
The European Commission has confirmed that the market entry of generic drugs is delayed and that company practices are among the causes in its final report on the competition inquiry into the pharmaceutical sector.
|
10 July 2009
An IMS press briefing earlier this month dramatically predicted a new world ranking of global pharma markets by 2013. But there's more to just knowing where these markets are in order to succeed in the 'new world order.'
|
10 July 2009
The European Commission has granted marketing authorization for Novo Nordisk's Victoza (liraglutide).
|
10 July 2009
Roche appears to want out of the Big Pharma crowd. A report from the UK's Financial Times claims that Roche will not renew its membership of the Association of the British Pharmaceutical Industry (ABPI), while the company has also confirmed that it has officially withdrawn from the US's Pharmaceutical Research and Manufacturers Association (PhRMA).
|
10 July 2009
With the World Health Organization (WHO) having declared the spread of swine flu "unstoppable" at a recent meeting in Mexico, there is increasing concern about counterfeits of Roche's anti-viral medicine Tamiflu, which are being purchased over the internet by panicking consumers.
|
| 
